1,150
Participants
Start Date
June 26, 2023
Primary Completion Date
January 1, 2026
Study Completion Date
January 14, 2027
Tumor and HLA Profiling
HLA genotyping and tumor tissue profiling for certain tumor-associated antigens and HLA LOH.
RECRUITING
Columbia University Herbert Irving Comprehensive Cancer Center, New York
RECRUITING
Allegheny Hospitals Network, Pittsburgh
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Orlando Health, Orlando
RECRUITING
Memorial Healthcare System, Hollywood
RECRUITING
University of Miami, Sylvester Comprehensive Cancer Center, Miami
RECRUITING
University of South Florida, Tampa
RECRUITING
Sarah Cannon Research Institute, Nashville
RECRUITING
Norton Cancer Institute, Louisville
RECRUITING
The Cleveland Clinic, Cleveland
RECRUITING
Oncology Hematology Care, Cincinnati
RECRUITING
Karmanos Cancer Institute, Detroit
RECRUITING
University of Minnesota, Masonic Cancer Center, Minneapolis
RECRUITING
University of Chicago, Chicago
RECRUITING
OU Health Stephenson Cancer Center, Oklahoma City
RECRUITING
Baylor College of Medicine, Houston
RECRUITING
HonorHealth Research and Innovation Institute, Scottsdale
RECRUITING
University of California San Diego, San Diego
RECRUITING
Providence Cancer Institute Franz Clinic, Portland
RECRUITING
Yale Cancer Center, New Haven
TScan Therapeutics, Inc.
INDUSTRY